Taro Pharmaceutical Indus Stock (NYSE: TARO)

Taro Pharmaceutical Indus Stock (NYSE:TARO), Trade Ideas

Taro Pharmaceutical Indus

Taro Pharmaceutical Industries Ltd produces, researches, develops, and markets pharmaceutical products. Its primary focus includes semi-solid formulations, such as creams and ointments, and other dosage forms such as liquids, capsules, and tablets. The company is engaged in the dermatological and topical, cardiovascular, neuropsychiatric, and anti-inflammatory therapeutic categories. Geographically, it derives a majority of its revenue from the United States and also has a presence in Canada, Israel, and Other Countries.

Long Ideas

News

Penny Stocks

Small Cap

Intraday Update

Markets

Movers

Trading Ideas

AAIC

ACON

AINC

ALLR

ATTO

AUVI

AVGO

AVIR

BBLN

CHPT

COIN

ENVB

ETRN

FANH

GDEV

GRNA

IDEX

IOVA

IRNT

LXRX

MCLD

MNPR

NMTR

NVDA

ONCR

PRST

QBTS

QTEK

RIOT

SANA

SEEL

SMFL

TARO

TCRX

TIGR

TTOO

UFAB

VIRI

WLDS

Gainers


	QualTek Services Inc.  (NASDAQ: QTEK) shares jumped 127.2% to $0.1740 after dropping around 21% on Friday. Qualtek Services recently filed voluntarily petitions for Chapter 11 bankruptcy.


Why Nvidia Shares Are Trading Higher By Over 5%? Here Are Other Stocks Moving In Tuesday&#39;s Mid-Day Session

Biotech

Earnings

Health Care

Legal

General

ALKS

ALVR

CDTX

INAB

LEGN

MYOV

SAVA

SMMT

SNGX

STRO

TEVA

VKTX

VTVT

Here&#39;s a roundup of top developments in the biotech space over the last 24 hours:

Daily Biotech Pulse: Teva&#39;s Opioids Settlement, Criminal Investigation Against Cassava, Durable Responses For IN8bio&#39;s Leukemia Therapy

ABBV

BIOC

BLTE

BNTX

CBAY

CYTK

GOVX

HLVX

NNVC

PTGX

REGN

RSLS

TNON

VRCA

WINT

Biotech stocks advanced in the week ending May 22, defying the broader market retreat. The defensive nature of the industry and stock-specific moves lent support.

The Week Ahead In Biotech (May 22-28): Verrica, Bristol-Myers Squibb FDA Decisions, Medtronic Earnings, Conference Presentations &amp; More

Taro Pharmaceutical Industries Ltd. Ordinary Shares

Taro Pharmaceutical Industries Ltd

Tarot

Taronis Fuels Inc

Krensavage Asset Management today sent the following message to a special committee evaluating Sun Pharmaceutical Industries Ltd.&#39;s bid for Taro Pharmaceutical Industries Ltd.
Dear Linda,
As the largest minority shareholder1&nbsp;of Taro Pharmaceutical Industries Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TARO#NYSE">TARO</a>), Krensavage Asset Management LLC remains opposed to Sun Pharmaceutical Industries Ltd.&#39;s inadequate bid to take Taro private.

Government

Regulations

Krensavage Asset Management Remains Opposed to Sun Pharma's Predatory Bid for Taro Pharma

Taro Pharmaceutical Indus (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TARO#NYSE">TARO</a>) reported quarterly earnings of $0.54 per share which beat the analyst consensus estimate of $0.30 by 80 percent. The company reported quarterly sales of $157.10 million which beat the analyst consensus estimate of $154.91 million by 1.42 percent. This is a 12.86 percent increase over sales of $139.20 million the same period last year.

Earnings Beats

Taro Pharmaceutical Indus Q3 2024 GAAP EPS $0.54 Beats $0.30 Estimate

Taro Pharmaceutical Indus (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TARO#NYSE">TARO</a>) reported quarterly sales of $157.10 million which beat the analyst consensus estimate of $154.91 million by 1.42 percent. This is a 12.86 percent increase over sales of $139.20 million the same period last year.

Taro Pharmaceutical Indus Q3 Sales $157.10M Beat $154.91M Estimate

<h3>Companies Reporting Before The Bell</h3>
&bull; Nokia (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOK#NYSE">NOK</a>) is projected to report quarterly earnings at $0.15 per share on revenue of $7.05 billion.
&bull; Popular (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BPOP#NASDAQ">BPOP</a>) is likely to report quarterly earnings at $1.61 per share on revenue of $538.72 million.
&bull; Carpenter Tech (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRS#NYSE">CRS</a>) is estimated to report quarterly earnings at $0.85 per share on revenue of $657.10 million.
&bull; Berkshire Hills Bancorp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BHLB#NYSE">BHLB</a>) is estimated to report quarterly earnings at $0.49 per share on revenue of $94.52 million.
&bull; NetScout Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTCT#NASDAQ">NTCT</a>) is projected to report quarterly earnings at $0.37 per share on revenue of $198.38 million.
&bull; NextEra Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NEE#NYSE">NEE</a>) is expected to report quarterly earnings at $0.49 per share on revenue of $5.70 billion.
&bull; Virtu Finl (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VIRT#NASDAQ">VIRT</a>) is estimated to report quarterly earnings at $0.41 per share on revenue of $286.54 million.
&bull; Blackstone (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BX#NYSE">BX</a>) is estimated to report quarterly earnings at $0.96 per share on revenue of $2.57 billion.
&bull; Global X Guru Index ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GURU#NYSE">GURU</a>) is estimated to report earnings for its fourth quarter.
&bull; Bread Finl Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BFH#NYSE">BFH</a>) is projected to report quarterly loss at $0.84 per share on revenue of $988.92 million.
&bull; MarineMax (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HZO#NYSE">HZO</a>) is projected to report quarterly earnings at $0.50 per share on revenue of $521.28 million.
&bull; Southwest Airlines (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LUV#NYSE">LUV</a>) is expected to report quarterly earnings at $0.11 per share on revenue of $6.74 billion.
&bull; CNX Resources (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNX#NYSE">CNX</a>) is estimated to report quarterly earnings at $0.29 per share on revenue of $400.13 million.
&bull; Humana (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HUM#NYSE">HUM</a>) is expected to report quarterly earnings at $1.82 per share on revenue of $25.39 billion.
&bull; Valero Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VLO#NYSE">VLO</a>) is expected to report quarterly earnings at $2.95 per share on revenue of $35.69 billion.
&bull; McCormick &amp; Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MKC#NYSE">MKC</a>) is estimated to report quarterly earnings at $0.79 per share on revenue of $1.79 billion.
&bull; Murphy Oil (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MUR#NYSE">MUR</a>) is likely to report quarterly earnings at $1.00 per share on revenue of $855.99 million.
&bull; Banc of California (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BANC#NYSE">BANC</a>) is estimated to report quarterly loss at $0.08 per share on revenue of $170.60 million.
&bull; STMicroelectronics (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STM#NYSE">STM</a>) is likely to report quarterly earnings at $0.95 per share on revenue of $4.31 billion.
&bull; Lakeland Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LBAI#NASDAQ">LBAI</a>) is estimated to report quarterly earnings at $0.32 per share on revenue of $73.80 million.
&bull; Heritage Financial (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HFWA#NASDAQ">HFWA</a>) is estimated to report quarterly earnings at $0.45 per share on revenue of $62.03 million.
&bull; Union Pacific (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNP#NYSE">UNP</a>) is likely to report quarterly earnings at $2.57 per share on revenue of $6.05 billion.
&bull; S&amp;T Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STBA#NASDAQ">STBA</a>) is likely to report quarterly earnings at $0.86 per share on revenue of $99.77 million.
&bull; LSI Industries (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LYTS#NASDAQ">LYTS</a>) is expected to report quarterly earnings at $0.17 per share on revenue of $114.67 million.
&bull; Comcast (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMCSA#NASDAQ">CMCSA</a>) is likely to report quarterly earnings at $0.79 per share on revenue of $30.50 billion.
&bull; Northrop Grumman (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOC#NYSE">NOC</a>) is likely to report quarterly earnings at $5.80 per share on revenue of $10.44 billion.
&bull; Mobileye Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MBLY#NASDAQ">MBLY</a>) is projected to report quarterly earnings at $0.27 per share on revenue of $639.80 million.
&bull; Dow (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DOW#NYSE">DOW</a>) is expected to report quarterly earnings at $0.40 per share on revenue of $10.37 billion.
&bull; Xerox Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XRX#NASDAQ">XRX</a>) is estimated to report quarterly earnings at $0.53 per share on revenue of $1.79 billion.
&bull; Old Republic Intl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ORI#NYSE">ORI</a>) is projected to report quarterly earnings at $0.71 per share on revenue of $1.97 billion.
&bull; OSI Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OSIS#NASDAQ">OSIS</a>) is projected to report quarterly earnings at $1.74 per share on revenue of $362.55 million.
&bull; Sherwin-Williams (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SHW#NYSE">SHW</a>) is likely to report quarterly earnings at $1.80 per share on revenue of $5.22 billion.
&bull; Marsh &amp; McLennan (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMC#NYSE">MMC</a>) is expected to report quarterly earnings at $1.63 per share on revenue of $5.54 billion.
&bull; TAL Education (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TAL#NYSE">TAL</a>) is projected to report quarterly earnings at $0.02 per share on revenue of $331.17 million.
&bull; Valley Ntl (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VLY#NASDAQ">VLY</a>) is estimated to report quarterly earnings at $0.25 per share on revenue of $468.14 million.
&bull; Applied Industrial Techs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AIT#NYSE">AIT</a>) is likely to report quarterly earnings at $2.11 per share on revenue of $1.06 billion.
&bull; American Airlines Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAL#NASDAQ">AAL</a>) is expected to report quarterly earnings at $0.10 per share on revenue of $13.02 billion.
&bull; NextEra Energy Partners (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NEP#NYSE">NEP</a>) is expected to report quarterly earnings at $0.16 per share on revenue of $343.45 million.
&bull; Alaska Air Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALK#NYSE">ALK</a>) is estimated to report quarterly earnings at $0.18 per share on revenue of $2.55 billion.
&bull; ConnectOne Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNOB#NASDAQ">CNOB</a>) is likely to report quarterly earnings at $0.45 per share on revenue of $63.03 million.
&bull; Amalgamated Financial (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMAL#NASDAQ">AMAL</a>) is likely to report quarterly earnings at $0.72 per share on revenue of $71.39 million.
&bull; Eagle Materials (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EXP#NYSE">EXP</a>) is likely to report quarterly earnings at $3.55 per share on revenue of $536.57 million.
&bull; First Foundation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FFWM#NYSE">FFWM</a>) is estimated to report quarterly earnings at $0.03 per share on revenue of $62.81 million.
&bull; RPC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RES#NYSE">RES</a>) is likely to report quarterly earnings at $0.18 per share on revenue of $370.73 million.
&bull; Independent Bank (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IBCP#NASDAQ">IBCP</a>) is likely to report quarterly earnings at $0.70 per share on revenue of $40.11 million.
&bull; Xcel Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XEL#NASDAQ">XEL</a>) is estimated to report quarterly earnings at $0.85 per share on revenue of $4.01 billion.
&bull; First Merchants (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FRME#NASDAQ">FRME</a>) is expected to report quarterly earnings at $0.87 per share on revenue of $165.48 million.
&bull; Lakeland Financial (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LKFN#NASDAQ">LKFN</a>) is projected to report quarterly earnings at $0.89 per share on revenue of $59.98 million.
&bull; Marine Prods (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MPX#NYSE">MPX</a>) is expected to report quarterly earnings at $0.19 per share on revenue of $54.78 million.
&bull; West Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WTBA#NASDAQ">WTBA</a>) is projected to report quarterly earnings at $0.31 per share on revenue of $18.82 million.
<h3>Companies Reporting After The Bell</h3>
&bull; Western Alliance (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WAL#NYSE">WAL</a>) is projected to report quarterly earnings at $1.88 per share on revenue of $699.44 million.
&bull; Glacier Bancorp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GBCI#NYSE">GBCI</a>) is likely to report quarterly earnings at $0.41 per share on revenue of $167.16 million.
&bull; Federated Hermes (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FHI#NYSE">FHI</a>) is expected to report quarterly earnings at $0.83 per share on revenue of $396.98 million.
&bull; CVRx (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CVRX#NASDAQ">CVRX</a>) is expected to report quarterly loss at $0.54 per share on revenue of $11.14 million.
&bull; Fair Isaac (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FICO#NYSE">FICO</a>) is estimated to report quarterly earnings at $5.06 per share on revenue of $390.89 million.
&bull; Levi Strauss (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LEVI#NYSE">LEVI</a>) is likely to report quarterly earnings at $0.43 per share on revenue of $1.66 billion.
&bull; Western Digital (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WDC#NASDAQ">WDC</a>) is estimated to report quarterly loss at $1.13 per share on revenue of $2.99 billion.
&bull; AppFolio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APPF#NASDAQ">APPF</a>) is expected to report quarterly earnings at $0.72 per share on revenue of $162.71 million.
&bull; Visa (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/V#NYSE">V</a>) is projected to report quarterly earnings at $2.34 per share on revenue of $8.54 billion.
&bull; L3Harris Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LHX#NYSE">LHX</a>) is estimated to report quarterly earnings at $3.31 per share on revenue of $5.29 billion.
&bull; Marten Transport (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRTN#NASDAQ">MRTN</a>) is projected to report quarterly earnings at $0.18 per share on revenue of $271.62 million.
&bull; Taro Pharmaceutical Indus (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TARO#NYSE">TARO</a>) is projected to report quarterly earnings at $0.30 per share on revenue of $154.91 million.
&bull; First of Long Island (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FLIC#NASDAQ">FLIC</a>) is expected to report quarterly earnings at $0.25 per share on revenue of $23.21 million.
&bull; USCB Financial Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/USCB#NASDAQ">USCB</a>) is estimated to report quarterly earnings at $0.22 per share on revenue of $17.25 million.
&bull; Third Coast Bancshares (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TCBX#NASDAQ">TCBX</a>) is projected to report quarterly earnings at $0.48 per share on revenue of $38.13 million.
&bull; First Western Financial (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MYFW#NASDAQ">MYFW</a>) is estimated to report quarterly earnings at $0.32 per share on revenue of $23.83 million.
&bull; Byline Bancorp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BY#NYSE">BY</a>) is expected to report quarterly earnings at $0.67 per share on revenue of $101.40 million.
&bull; T-Mobile US (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TMUS#NASDAQ">TMUS</a>) is projected to report quarterly earnings at $1.90 per share on revenue of $19.64 billion.
&bull; KLA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KLAC#NASDAQ">KLAC</a>) is projected to report quarterly earnings at $5.91 per share on revenue of $2.46 billion.
&bull; SouthState (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SSB#NYSE">SSB</a>) is likely to report quarterly earnings at $1.54 per share on revenue of $417.72 million.
&bull; Intel (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTC#NASDAQ">INTC</a>) is expected to report quarterly earnings at $0.45 per share on revenue of $15.16 billion.
&bull; Flushing Financial (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FFIC#NASDAQ">FFIC</a>) is estimated to report quarterly earnings at $0.23 per share on revenue of $48.12 million.
&bull; Weyerhaeuser (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WY#NYSE">WY</a>) is estimated to report quarterly earnings at $0.17 per share on revenue of $1.86 billion.
&bull; First Financial Bancor (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FFBC#NASDAQ">FFBC</a>) is expected to report quarterly earnings at $0.61 per share on revenue of $207.32 million.
&bull; Arthur J. Gallagher (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AJG#NYSE">AJG</a>) is likely to report quarterly earnings at $1.85 per share on revenue of $2.36 billion.
&bull; Capital One Finl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COF#NYSE">COF</a>) is likely to report quarterly earnings at $2.64 per share on revenue of $9.46 billion.
&bull; Financial Institutions (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FISI#NASDAQ">FISI</a>) is likely to report quarterly earnings at $0.71 per share on revenue of $40.32 million.
&bull; Ameris (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABCB#NASDAQ">ABCB</a>) is projected to report quarterly earnings at $1.10 per share on revenue of $264.66 million.
&bull; Hilltop Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HTH#NYSE">HTH</a>) is likely to report quarterly earnings at $0.40 per share on revenue of $113.80 million.
&bull; MidWestOne Financial Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MOFG#NASDAQ">MOFG</a>) is likely to report quarterly earnings at $0.49 per share on revenue of $34.02 million.
&bull; Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TBBK#NASDAQ">TBBK</a>) is projected to report quarterly earnings at $0.95 per share on revenue of $90.65 million.
&bull; Customers Bancorp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CUBI#NYSE">CUBI</a>) is likely to report quarterly earnings at $1.72 per share on revenue of $173.26 million.
&bull; WSFS Financial (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WSFS#NASDAQ">WSFS</a>) is expected to report quarterly earnings at $1.05 per share on revenue of $177.61 million.
&bull; Olin (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OLN#NYSE">OLN</a>) is likely to report quarterly earnings at $0.19 per share on revenue of $1.52 billion.
&bull; Primis Finl (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FRST#NASDAQ">FRST</a>) is expected to report quarterly earnings at $0.28 per share on revenue of $27.05 million.
&bull; Provident Finl Servs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PFS#NYSE">PFS</a>) is projected to report quarterly earnings at $0.41 per share on revenue of $94.12 million.
&bull; Seacoast Banking (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBCF#NASDAQ">SBCF</a>) is expected to report quarterly earnings at $0.40 per share on revenue of $135.57 million.
&bull; GSI Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GSIT#NASDAQ">GSIT</a>) is expected to report earnings for its third quarter.
&bull; Associated Banc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ASB#NYSE">ASB</a>) is projected to report quarterly earnings at $0.52 per share on revenue of $275.24 million.
&bull; Midland States Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSBI#NASDAQ">MSBI</a>) is expected to report quarterly earnings at $0.79 per share on revenue of $75.49 million.
&bull; SB Finl Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBFG#NASDAQ">SBFG</a>) is expected to report quarterly earnings at $0.35 per share on revenue of $9.40 million.
&bull; Eastern Bankshares (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EBC#NASDAQ">EBC</a>) is likely to report quarterly earnings at $0.20 per share on revenue of $129.71 million.
&bull; BayFirst Financial (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BAFN#NASDAQ">BAFN</a>) is likely to report earnings for its fourth quarter.
This article was generated by Benzinga&#39;s automated content engine and reviewed by an editor.

ABCB

AMAL

APPF

BAFN

BANC

BHLB

BPOP

CMCSA

CNOB

CUBI

CVRX

FFBC

FFIC

FFWM

FICO

FISI

FLIC

FRME

FRST

GBCI

GSIT

GURU

HFWA

IBCP

INTC

KLAC

LBAI

LEVI

LKFN

LYTS

MBLY

MOFG

MRTN

MSBI

MYFW

NTCT

OSIS

SBCF

SBFG

STBA

TBBK

TCBX

TMUS

USCB

VIRT

WSFS

WTBA

Earnings Scheduled For January 25, 2024

Taro Pharmaceutical Indus (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TARO#NYSE">TARO</a>) is set to give its latest quarterly earnings report on Thursday, 2024-01-25. Here's what investors need to know before the announcement.
Analysts estimate that Taro Pharmaceutical Indus will report an earnings per share (EPS) of $0.30. 
Taro Pharmaceutical Indus bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Past Earnings Performance</h3>
Last quarter the company beat EPS by $0.20, which was followed by a 2.3% drop in the share price the next day.
Here's a look at Taro Pharmaceutical Indus's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
<th>Q3 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.18</td>
<td>0.31</td>
<td>0.31</td>
<td>0.87</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.38</td>
<td>0.40</td>
<td>0.18</td>
<td>0.19</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-2.3%</td>
<td>0.11%</td>
<td>-5.68%</td>
<td>-1.26%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2024/1706122910_0.png" alt="eps graph" />
<h3>Stock Performance</h3>
Shares of Taro Pharmaceutical Indus were trading at $42.07 as of January 23. Over the last 52-week period, shares are up 37.71%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. 
<a href="https://www.benzinga.com/quote/TARO/earnings">To track all earnings releases for Taro Pharmaceutical Indus visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Preview For Taro Pharmaceutical Indus

HC Wainwright &amp; Co. analyst Raghuram Selvaraju downgrades Taro Pharmaceutical Indus (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TARO#NYSE">TARO</a>) from Buy to Neutral and maintains the price target from $43 to $43.

Downgrades

Price Target

Analyst Ratings

HC Wainwright & Co. Downgrades Taro Pharmaceutical Indus to Neutral, Maintains Price Target to $43

Agreed Price of US$43.00 per Share to Deliver 48% Premium to Unaffected Price on May 25, 2023

Taro Pharmaceutical Entered Into Definitive Merger Agreement With Sun Pharma; Sun Pharma To Acquire All Taro's Outstanding Ordinary Shares Of Taro For $43/Share

Taro Pharmaceutical Indus (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TARO#NYSE">TARO</a>) reported quarterly earnings of $0.38 per share which beat the analyst consensus estimate of $0.18 by 111.11 percent. This is a 42.42 percent decrease over earnings of $0.66 per share from the same period last year. The company reported quarterly sales of $148.20 million which missed the analyst consensus estimate of $161.14 million by 8.03 percent. This is a 13.57 percent increase over sales of $130.50 million the same period last year.

Taro Pharmaceutical Indus Q2 2023 Adj.EPS $0.38 Beats $0.18 Estimate, Sales $148.20M Miss $161.14M Estimate

SBSI

SHYF

SILC

SKYW

SPSC

SSNC

STAG

STRT

THRM

TIGO

TSCO

TXRH

ULBI

ULCC

VALE

VRSN

XPRO

ZDGE

ZYXI

Earnings Scheduled For October 26, 2023

Taro Pharmaceutical Indus (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TARO#NYSE">TARO</a>) is set to give its latest quarterly earnings report on Thursday, 2023-10-26. Here's what investors need to know before the announcement.
Analysts estimate that Taro Pharmaceutical Indus will report an earnings per share (EPS) of $0.18. 
Taro Pharmaceutical Indus bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Historical Earnings Performance</h3>
Last quarter the company beat EPS by $0.09, which was followed by a 0.11% increase in the share price the next day.
Here's a look at Taro Pharmaceutical Indus's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
<th>Q3 2023</th>
<th>Q2 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.31</td>
<td>0.31</td>
<td>0.87</td>
<td>0.84</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.40</td>
<td>0.18</td>
<td>0.19</td>
<td>0.66</td>
</tr>
<tr>
<td>Price Change %</td>
<td>0.11%</td>
<td>-5.68%</td>
<td>-1.26%</td>
<td>-2.09%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2023/1698253323_0.png" alt="eps graph" />
<h3>Stock Performance</h3>
Shares of Taro Pharmaceutical Indus were trading at $33.5 as of October 24. Over the last 52-week period, shares are up 1.55%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. 
<a href="https://www.benzinga.com/quote/TARO/earnings">To track all earnings releases for Taro Pharmaceutical Indus visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Taro Pharmaceutical Indus Earnings Preview

Taro Pharmaceutical Indus (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TARO#NYSE">TARO</a>) reported quarterly earnings of $0.27 per share. This is a 27.03 percent decrease over earnings of $0.37 per share from the same period last year. The company reported $158.89 million in sales this quarter. This is a 1.42 percent increase over sales of $156.66 million the same period last year.

Taro Pharmaceutical Indus Q1 EPS $0.27 Down From $0.37 YoY, Sales $158.89M Up From $156.66M YoY